相关实验视频

Updated: May 7, 2025

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

前列腺管道腺癌具有MLH1拷贝数损失,微卫星不稳定性高和BRCA2突变

Jianping Li¹, Tie Chong¹, Li Wang¹

¹Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, 710004 China.

International cancer conference journal

|January 6, 2025

概括

这项研究详细介绍了一种罕见的前列腺癌与不匹配修复缺陷 (MMRd) 和MLH1损失的病例. 患有MSI高的前列腺癌和BRCA2突变的患者对免疫疗法加上雄激素剥夺疗法反应良好.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

不匹配修复缺陷 (MMRd) 或微卫星不稳定性高 (MSI-H) 在前列腺癌中不常见,通常与导管组织学有关.
在MMRd瘤中,MLH1拷贝数损失非常罕见,使其在前列腺癌中的存在成为一个重要的发现.

研究的目的:

报告一个独特的前列腺管道腺癌病例,显示MLH1拷贝数丢失,MSI高状态和BRCA2突变.
在这种罕见的MMRd前列腺癌病例中,研究免疫疗法与雄激素缺乏治疗 (ADT) 结合的潜在益处.

主要方法:

下一代测序 (NGS) 用于分析瘤突变负担,MSI状态,MLH1拷贝数,并识别致病突变.
该患者接受了手术后的雄激素剥夺疗法 (ADT) 和免疫疗法 (tislelizumab).

主要成果:

患者的前列腺管腺癌的特征是瘤突变,MSI高状态,怀疑双性MLH1损失,以及一种致病性BRCA2变异.
在ADT和tislelizumab治疗后,该患者实现了PSA水平的显著降低,并在1年的随访中没有在盆腔MRI上显示异常.

结论:

这一案例强调了MMRd前列腺癌复杂的分子格局.
免疫疗法加ADT的积极反应表明,对于这种罕见的癌症亚型的选择患者来说,这是一种潜在的治疗途径.

关键词:

复制号码丢失复制号码丢失 MLH1 一个问题不匹配的修复缺陷的缺陷前列腺管道腺癌前列腺管道腺癌.

更多相关视频

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...